Relationship [qlco]
Endothelial [tisu]
Functions [ftcn]
Acetylsalicylic Acid [orch, phsu]
Resistance [menp]
newly [idcn]
Diagnosed [fndg]
hypertensive [fndg]
Patients [podg]
investigate [ftcn]
effects [qlco]
Dose-dependent [qnco]
Aspirin [orch, phsu]
Endothelial [tisu]
Functions [ftcn]
ASPIRIN RESISTANCE [fndg]
newly [idcn]
Diagnosed [fndg]
hypertensive [fndg]
Patients [podg]
Previous [tmco]
Drug Therapy [topp]
Cardiac complications [patf]
Hypothesis [idcn]
acetylsalicyclic acid [orch, phsu]
Endothelial [tisu]
function [phsf]
Methods [inpr]
Eight [qnco]
hypertensive [fndg]
Patients [podg]
HEALTHY SUBJECTS [popg]
Control Group [grup]
included [ftcn]
Study [mnob]
Endothelial [tisu]
Functions [ftcn]
Control Groups [grup]
Evaluated [ftcn]
Brachial Artery [bpoc]
Control Groups [grup]
divided [ftcn]
Group [idcn]
mg% [qnco]
mg% [qnco]
Aspirin [orch, phsu]
GIVEN [cnce]
Separate [spco]
Group [idcn]
1 Week [tmco]
1 Week [tmco]
Endothelial [tisu]
Functions [ftcn]
ASPIRIN RESISTANCE [fndg]
Examined [fndg]
Platelet Function [lbpr]
Analyzer [medd]
dade [orch]
Germany [geoa]
baseline [bodm]
Flow [npop]
mediated [socb]
Dilatation [topp]
Percent [qnco]
hypertensive [fndg]
Patients [podg]
Control Group [grup]
P NOS [aapp, imft]
frequency [qnco]
Acetylsalicylic Acid [orch, phsu]
Resistance [menp]
hypertensive [fndg]
Group [idcn]
P NOS [aapp, imft]
Not significant [fndg]
Acetylsalicylic Acid [orch, phsu]
Resistance [menp]
mg% [qnco]
mg% [qnco]
hypertensive [fndg]
Patients [podg]
P NOS [aapp, imft]
Not significant [fndg]
Flow [npop]
mediated [socb]
Dilatation [topp]
Percent [qnco]
Increased [qnco]
hypertensive [fndg]
Group [idcn]
Acetylsalicylic Acid [orch, phsu]
treatment [ftcn]
Flow [npop]
mediated [socb]
Dilatation [topp]
Percentage [qnco]
Increased [qnco]
hypertensive [fndg]
Patients [podg]
Acetylsalicylic Acid [orch, phsu]
Resistance [menp]
P NOS [aapp, imft]
Acetylsalicylic Acid [orch, phsu]
Resistance [menp]
P NOS [aapp, imft]
0.012" [qnco]
Acetylsalicylic Acid [orch, phsu]
Resistance [menp]
Conclusions [idcn]
Endothelial [tisu]
Functions [ftcn]
Impaired [ftcn]
hypertensive [fndg]
Patients [podg]
Compared [acty]
Control Group [grup]
Endothelial [tisu]
Functions [ftcn]
Improved [qlco]
Acetylsalicylic Acid [orch, phsu]
Doses [qnco]
hypertensive [fndg]
Patients [podg]
Acetylsalicylic Acid [orch, phsu]
Resistance [menp]
Authors [prog]
Funding [qnco]
financial [qnco]
Relationships [qlco]
Conflict of Interest [idcn]
